Oxidant-induced inhibition of the plasma membrane Ca2+-ATPase in pancreatic acinar cells: role of the mitochondria

Am J Physiol Cell Physiol. 2008 Nov;295(5):C1247-60. doi: 10.1152/ajpcell.00083.2008. Epub 2008 Sep 11.

Abstract

Impairment of the normal spatiotemporal pattern of intracellular Ca(2+) ([Ca(2+)](i)) signaling, and in particular, the transition to an irreversible "Ca(2+) overload" response, has been implicated in various pathophysiological states. In some diseases, including pancreatitis, oxidative stress has been suggested to mediate this Ca(2+) overload and the associated cell injury. We have previously demonstrated that oxidative stress with hydrogen peroxide (H(2)O(2)) evokes a Ca(2+) overload response and inhibition of plasma membrane Ca(2+)-ATPase (PMCA) in rat pancreatic acinar cells (Bruce JI and Elliott AC. Am J Physiol Cell Physiol 293: C938-C950, 2007). The aim of the present study was to further examine this oxidant-impaired inhibition of the PMCA, focusing on the role of the mitochondria. Using a [Ca(2+)](i) clearance assay in which mitochondrial Ca(2+) uptake was blocked with Ru-360, H(2)O(2) (50 microM-1 mM) markedly inhibited the PMCA activity. This H(2)O(2)-induced inhibition of the PMCA correlated with mitochondrial depolarization (assessed using tetramethylrhodamine methylester fluorescence) but could occur without significant ATP depletion (assessed using Magnesium Green fluorescence). The H(2)O(2)-induced PMCA inhibition was sensitive to the mitochondrial permeability transition pore (mPTP) inhibitors, cyclosporin-A and bongkrekic acid. These data suggest that oxidant-induced opening of the mPTP and mitochondrial depolarization may lead to an inhibition of the PMCA that is independent of mitochondrial Ca(2+) handling and ATP depletion, and we speculate that this may involve the release of a mitochondrial factor. Such a phenomenon may be responsible for the Ca(2+) overload response, and for the transition between apoptotic and necrotic cell death thought to be important in many disease states.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Animals
  • Antimycin A / pharmacology
  • Biological Assay
  • Bongkrekic Acid / pharmacology
  • Calcium Signaling* / drug effects
  • Carbonyl Cyanide m-Chlorophenyl Hydrazone / pharmacology
  • Cyclosporine / pharmacology
  • Hydrogen Peroxide / metabolism
  • Membrane Potential, Mitochondrial
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Mitochondrial Membrane Transport Proteins / metabolism
  • Mitochondrial Permeability Transition Pore
  • Oligomycins / pharmacology
  • Oxidative Stress* / drug effects
  • Pancreas, Exocrine / drug effects
  • Pancreas, Exocrine / enzymology*
  • Plasma Membrane Calcium-Transporting ATPases / antagonists & inhibitors
  • Plasma Membrane Calcium-Transporting ATPases / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Reproducibility of Results
  • Ruthenium Compounds / pharmacology
  • Time Factors
  • Uncoupling Agents / pharmacology

Substances

  • Mitochondrial Membrane Transport Proteins
  • Mitochondrial Permeability Transition Pore
  • Oligomycins
  • Ru 360
  • Ruthenium Compounds
  • Uncoupling Agents
  • Bongkrekic Acid
  • Carbonyl Cyanide m-Chlorophenyl Hydrazone
  • Antimycin A
  • Cyclosporine
  • Adenosine Triphosphate
  • Hydrogen Peroxide
  • Plasma Membrane Calcium-Transporting ATPases